The Pharmaceutical Journal
Vol 273 No 7319 p455
2 October 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

IVG not recommended for MS

Intravenous immunoglobulin (IVG) cannot be recommended for patients with secondary progressive multiple sclerosis, say researchers.

In a recent study, IVG, which is under investigation for potential use in multiple sclerosis, showed no clinical benefit in patients with secondary progressive MS. A higher rate of DVT was also seen in the IVG group, suggesting some potential risks with this treatment (Lancet 2004;364:1149).